PS ratio:
N/ASummary
- DNLI price to sales ratio is not available.
Performance
DNLI PS ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PS ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
DNLI PS ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | -0.9% | -0.9% | 0.0% |
| 1 m1 month | - | +10.0% | +10.0% | - |
| 3 m3 months | - | +4.9% | +5.6% | 0.0% |
| 6 m6 months | - | -8.0% | -7.3% | - |
| ytdytd | - | -24.6% | -23.6% | - |
| 1 y1 year | - | -40.0% | -38.7% | -100.0% |
| 5 y5 years | - | -51.3% | -32.9% | -100.0% |
DNLI PS ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | 3508.51 | 2891.55 | ||
| 3 y | 3-year | 3508.51 | 6.57 | ||
| 5 y | 5-year | 3508.51 | 6.57 | ||
| alltime | all time | 3508.51 | 6.57 |
DNLI PS ratio History
| Date | Value |
|---|---|
| 2023 | 8.98(-74.2%) |
| 2022 | 34.86(-68.9%) |
| 2021 | 112.08(+272.6%) |
| Date | Value |
|---|---|
| 2020 | 30.08(-52.1%) |
| 2019 | 62.81(+314.9%) |
| 2018 | 15.14 |
FAQ
- What is the all time high PS ratio for Denali Therapeutics Inc.?
What is the all time high PS ratio for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high price to sales ratio is 3508.51